WF-47-JS03   Click here for help

GtoPdb Ligand ID: 10709

Synonyms: compound 1 [Mathison et al., 2020] | WF47JS03
Compound class: Synthetic organic
Comment: WF-47-JS03 is a RET (REarranged during Transfection) kinase inhibitor that was designed for anti-cancer potential [1]. It is orally bioavailable, but was not well tolerated in mice at higher doses, indicating a narrow therapeutic window.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 89.94
Molecular weight 514.31
XLogP 6.33
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES COc1cc(ccc1OC)c1cnn2c1nc(NC1CC(C)(C)N(C(C1)(C)C)C)c(c2N)c1ccccc1
Isomeric SMILES COc1cc(ccc1OC)c1cnn2c1nc(NC1CC(C)(C)N(C(C1)(C)C)C)c(c2N)c1ccccc1
InChI InChI=1S/C30H38N6O2/c1-29(2)16-21(17-30(3,4)35(29)5)33-27-25(19-11-9-8-10-12-19)26(31)36-28(34-27)22(18-32-36)20-13-14-23(37-6)24(15-20)38-7/h8-15,18,21H,16-17,31H2,1-7H3,(H,33,34)
1. Mathison CNJ, Chianelli D, Ruckler PV, Nelson J, Roland J, Huang Z, Yang Y, Jiang J, Xie YF, Epple R et al.. (2020)
Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma.
ACS Med Chem Lett, [Articles ASAP]. DOI: 10.1021/acsmedchemlett.0c00015